Part V. Adjuvant therapies for ductal carcinoma in situ

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026

Trehalose Exerts Selective Cytotoxicity Against Tongue Squamous Cell Carcinoma Cells While Exhibiting Limited Cytotoxicity Toward Normal Oral Squamous Cells.

OncoTargets and therapy·2026

Pathological Complete Response following Pembrolizumab Combined with Gemcitabine and Cisplatin Therapy for Initially Unresectable Intrahepatic Cholangiocarcinoma: A Case Report.

Case reports in oncology·2026

Anti-angiogenic therapy in thymic carcinoma: a narrative review of current evidence and emerging combinations.

Mediastinum (Hong Kong, China)·2026

Narrative review: locally advanced thymoma-do we really need induction therapy before extended resection?

Mediastinum (Hong Kong, China)·2026

Invasive thymoma with rapid response to cisplatin, doxorubicin and cyclophosphamide (PAC) chemotherapy, after an early postoperative recurrence-a case report.

Mediastinum (Hong Kong, China)·2026

Related Experiment Videos

Part V. Adjuvant therapies for ductal carcinoma in situ

Related Concept Videos

TET1 non-catalytic activity shapes the chromatin landscape that directs de novo methylation establishment in the male germline.

Network-based clustering and statistical evaluation to elucidate structure-activity relationships of EZH2 inhibitors.

Exploring chemical space, scaffold diversity, and activity landscape of spleen tyrosine kinase active inhibitors.

Scaling Up Maternal Mental healthcare by Increasing access to Treatment (SUMMIT) through non-specialist providers and telemedicine: a study protocol for a non-inferiority randomized controlled trial.

Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease.

Therapist Reports of EBP Client Engagement Challenges in Sessions with Diverse Youth and Families in Community Mental Health Settings.

Salvage outcomes with teclistamab after BCMA-directed therapy failure in relapsed/refractory multiple myeloma: a systematic review and meta-analysis.

Unraveling lung cancer complexity: Spatial omics in tumor microenvironment characterization and precision medicine.

Predictors of change in cognitive function for patients with cancer treated with allogeneic hematopoietic cell transplant.

Spatial transcriptomics of primary and metastatic ALK-rearranged NSCLC reveals site-specific adaptations.

Intraductal papillary mucinous neoplasms: a comprehensive analysis combining genetic, immunopathological and clinical management.

Experience of the implementation of a lung cancer screening program at the Hospital General de Catalunya (Barcelona, Spain).

Confounding by indication in the evaluation of neoadjuvant chemotherapy: a sequential Cox analysis of an eight-year single-centre breast cancer cohort.

Trehalose Exerts Selective Cytotoxicity Against Tongue Squamous Cell Carcinoma Cells While Exhibiting Limited Cytotoxicity Toward Normal Oral Squamous Cells.

Pathological Complete Response following Pembrolizumab Combined with Gemcitabine and Cisplatin Therapy for Initially Unresectable Intrahepatic Cholangiocarcinoma: A Case Report.

Anti-angiogenic therapy in thymic carcinoma: a narrative review of current evidence and emerging combinations.

Narrative review: locally advanced thymoma-do we really need induction therapy before extended resection?

Invasive thymoma with rapid response to cisplatin, doxorubicin and cyclophosphamide (PAC) chemotherapy, after an early postoperative recurrence-a case report.

Related Experiment Videos

Part V. Adjuvant therapies for ductal carcinoma in situ

Related Concept Videos

Related Articles